Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Linder

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|September 28, 2007
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 alleleEdward P Womack, Kristen K Reynolds, Roland Valdes, et al.
Clinics in Laboratory Medicine|December 9, 2008
Dynamic pharmacogenetic models in anticoagulation therapyMarjorie Bon Homme, Kristen K Reynolds, Roland Valdes, et al.
Personalized Medicine|May 17, 2018
Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine programKristen K Reynolds, Deanne L Pierce, Frederick Weitendorf, et al.
Molecular Diagnosis & Therapy|June 22, 2016
Liquid Biopsies in Oncology and the Current Regulatory LandscapeLindsay N Strotman, Lori M Millner, Roland Valdes, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Suppression of cytochrome P450 2E1 promoter activity by interferon-gamma and loss of response due to the -71G>T nucleotide polymorphism of the CYP2E1*7B alleleLing O Qiu, Mark W Linder, Deborah M Antonino-Green, et al.
Personalized Medicine|May 23, 2018
Pharmacogenetic testing of CYP2D6 in patients with aripiprazole-related extrapyramidal symptoms: a case-control studyAnton A Subuh Surja, Kristen K Reynolds, Mark W Linder, et al.
Pharmacogenomics|April 16, 2019
Cell-free DNA diagnostics: current and emerging applications in oncologyPenn Muluhngwi, Roland Valdes, Rafael Fernandez-Botran, et al.
The Journal of Applied Laboratory Medicine|March 6, 2021
A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing UtilizationCierra N Sharp, Anita Fletcher, Penn Muluhngwi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 21, 2006
Analysis of ligand binding by bioaffinity mass spectrometryYusheng Zhu, Roland Valdes, Christine Q Simmons, et al.
Clinical Chemistry and Laboratory Medicine|May 9, 2020
External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international surveyDeborah A Payne, Graciela Russomando, Mark W Linder, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|September 28, 2007
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 alleleEdward P Womack, Kristen K Reynolds, Roland Valdes, et al.
Clinics in Laboratory Medicine|December 9, 2008
Dynamic pharmacogenetic models in anticoagulation therapyMarjorie Bon Homme, Kristen K Reynolds, Roland Valdes, et al.
Personalized Medicine|May 17, 2018
Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine programKristen K Reynolds, Deanne L Pierce, Frederick Weitendorf, et al.
Molecular Diagnosis & Therapy|June 22, 2016
Liquid Biopsies in Oncology and the Current Regulatory LandscapeLindsay N Strotman, Lori M Millner, Roland Valdes, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Suppression of cytochrome P450 2E1 promoter activity by interferon-gamma and loss of response due to the -71G>T nucleotide polymorphism of the CYP2E1*7B alleleLing O Qiu, Mark W Linder, Deborah M Antonino-Green, et al.
Personalized Medicine|May 23, 2018
Pharmacogenetic testing of CYP2D6 in patients with aripiprazole-related extrapyramidal symptoms: a case-control studyAnton A Subuh Surja, Kristen K Reynolds, Mark W Linder, et al.
Pharmacogenomics|April 16, 2019
Cell-free DNA diagnostics: current and emerging applications in oncologyPenn Muluhngwi, Roland Valdes, Rafael Fernandez-Botran, et al.
The Journal of Applied Laboratory Medicine|March 6, 2021
A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing UtilizationCierra N Sharp, Anita Fletcher, Penn Muluhngwi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 21, 2006
Analysis of ligand binding by bioaffinity mass spectrometryYusheng Zhu, Roland Valdes, Christine Q Simmons, et al.
Clinical Chemistry and Laboratory Medicine|May 9, 2020
External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international surveyDeborah A Payne, Graciela Russomando, Mark W Linder, et al.
Pageof 4